Q2 roll call for mid-sized pharma, as companies face generics trough
August 01 2012
First-half earnings are in for Allergan, Shire and UCB, with the three companies striking an upbeat tone on revenues.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.